Could a gut makeover help Alzheimer's? first safety trial begins
NCT ID NCT07332260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing whether a fecal microbiota transplant (FMT) is safe and feasible for people with mild-to-moderate Alzheimer's disease. Ten participants will receive the transplant via colonoscopy, and researchers will monitor side effects, recruitment rates, and changes in gut bacteria. The goal is to see if this approach is worth studying further for easing Alzheimer's symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of North Norway, Tromsø
RECRUITINGTromsø, Troms, 9016, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your brain help unlock Alzheimer's secrets?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a new drug tame Alzheimer's? early trial aims to find out
- A scan that sees Alzheimer's tangles? trial puts tau tracer to the test
- Can a pill clear the toxic proteins behind Alzheimer's?
- A light switch for better sleep? Alzheimer's trial tests wireless circadian lighting